299 related articles for article (PubMed ID: 11532423)
1. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?
Weber JC; Nakano H; Bachellier P; Oussoultzoglou E; Inoue K; Shimura H; Wolf P; Chenard-Neu MP; Jaeck D
Am J Surg; 2001 Jul; 182(1):81-8. PubMed ID: 11532423
[TBL] [Abstract][Full Text] [Related]
2. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
[TBL] [Abstract][Full Text] [Related]
3. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer.
Nagashima I; Oka T; Hamada C; Naruse K; Osada T; Muto T
Am J Gastroenterol; 1999 Mar; 94(3):739-43. PubMed ID: 10086660
[TBL] [Abstract][Full Text] [Related]
4. Hepatic resection for colorectal metastases: analysis of prognostic factors.
Ambiru S; Miyazaki M; Isono T; Ito H; Nakagawa K; Shimizu H; Kusashio K; Furuya S; Nakajima N
Dis Colon Rectum; 1999 May; 42(5):632-9. PubMed ID: 10344686
[TBL] [Abstract][Full Text] [Related]
5. Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer.
Onodera H; Mori A; Nagayama S; Fujimoto A; Tachibana T; Yonenaga Y; Tsuruyama T
Int J Colorectal Dis; 2005 Nov; 20(6):477-84. PubMed ID: 15846499
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
7. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
Hohenberger P; Schlag PM; Gerneth T; Herfarth C
Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
9. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
[TBL] [Abstract][Full Text] [Related]
12. Liver metastases from colorectal cancer: present surgical approach.
Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
[TBL] [Abstract][Full Text] [Related]
13. [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions].
Scheele J; Altendorf-Hofmann A; Stangl R; Schmidt K
Swiss Surg; 1996; Suppl 4():4-17. PubMed ID: 8963836
[TBL] [Abstract][Full Text] [Related]
14. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver.
Tanaka K; Shimada H; Fujii Y; Endo I; Sekido H; Togo S; Ike H
Langenbecks Arch Surg; 2004 Oct; 389(5):371-9. PubMed ID: 15605168
[TBL] [Abstract][Full Text] [Related]
15. Resection of synchronous liver metastases from colorectal cancer.
Fujita S; Akasu T; Moriya Y
Jpn J Clin Oncol; 2000 Jan; 30(1):7-11. PubMed ID: 10770561
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of clinical and pathologic risk factors in liver resection for hepatic colorectal metastases.
Zhou L; Zhag G; Tang T; Lian R; Wang W
J Cancer Res Ther; 2013 Nov; 9 Suppl():S178-82. PubMed ID: 24516057
[TBL] [Abstract][Full Text] [Related]
17. Outcome of surgical treatment of synchronous liver metastases from colorectal cancer.
Taniai N; Yoshida H; Mamada Y; Matsumoto S; Mizuguchi Y; Suzuki H; Furukawa K; Akimaru K; Tajiri T
J Nippon Med Sch; 2006 Apr; 73(2):82-8. PubMed ID: 16641532
[TBL] [Abstract][Full Text] [Related]
18. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases.
Elias D; Cavalcanti A; Sabourin JC; Pignon JP; Ducreux M; Lasser P
J Surg Oncol; 1998 Oct; 69(2):88-93. PubMed ID: 9808511
[TBL] [Abstract][Full Text] [Related]
19. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection.
Passot G; Denbo JW; Yamashita S; Kopetz SE; Chun YS; Maru D; Overman MJ; Brudvik KW; Conrad C; Aloia TA; Vauthey JN
Surgery; 2017 Feb; 161(2):332-340. PubMed ID: 27592215
[TBL] [Abstract][Full Text] [Related]
20. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
